Table 2.
Patient Characteristics by Type of Physician*
| Patient Characteristics | Study Patients (N = 1,820) | ID Physicians (N = 793) | General Medicine Experts (N = 878) | General Medicine Non-experts (N = 149) |
|---|---|---|---|---|
| Age (SD) | 39.2 (8.6) | 39.4 (8.3) | 39.1 (9.0) | 39.1 (8.4) |
| Gender, % | + | |||
| Male | 77.6 | 72.9 | 81.2 | 84.2 |
| Female | 22.4 | 27.1 | 18.8 | 15.6 |
| Race, % | + | |||
| White | 50.1 | 50.6 | 47.8 | 58.7 |
| African American | 31.8 | 28.2 | 36.0 | 30.0 |
| Hispanic | 15.2 | 19.3 | 12.6 | 7.0 |
| Other | 2.9 | 1.9 | 3.6 | 4.2 |
| Education, % | ||||
| Less than high school | 24.3 | 23.4 | 27.1 | 15.2 |
| High school graduate | 28.0 | 30.3 | 25.6 | 27.8 |
| Some college | 28.0 | 27.6 | 27.8 | 30.7 |
| College graduate | 19.7 | 18.7 | 19.5 | 26.3 |
| Insurance, % | ||||
| No insurance | 14.1 | 7.7 | 21.6 | 10.6 |
| Medicaid | 28.7 | 32.0 | 26.4 | 23.2 |
| Medicare | 23.7 | 25.7 | 21.6 | 24.1 |
| Private | 33.5 | 34.7 | 30.4 | 42.1 |
| Income, % | ||||
| <$5,000 | 19.3 | 17.7 | 22.7 | 11.5 |
| $5 – $10k | 25.7 | 25.6 | 26.0 | 24.3 |
| $10k–$25k | 26.1 | 26.3 | 26.3 | 24.1 |
| <$25k | 28.9 | 30.5 | 25.0 | 40.1 |
| Lowest CD4 counts, % | ||||
| ≥500 Cells/mm3 | 8.2 | 8.6 | 7.2 | 11.0 |
| 200–499 Cells/mm3 | 36.3 | 32.7 | 40.7 | 33.4 |
| 50–199 Cells/mm3 | 29.8 | 30.2 | 29.7 | 28.0 |
| <50 Cells/mm3 | 25.8 | 28.5 | 22.5 | 27.6 |
| Risk, % | ++ | |||
| IVDA | 23.3 | 28.8 | 18.4 | 19.0 |
| Man sex with man | 49.0 | 41.7 | 53.5 | 64.0 |
| Heterosexual contact | 18.6 | 21.0 | 18.4 | 7.6 |
| Other transmission | 9.1 | 8.6 | 9.6 | 9.3 |
| Attitude toward taking antiretrovirals (N = 1,811), % | ++** | |||
| Definitely worth it | 49.0 | 51.2 | 47.1 | 47.3 |
| Probably worth it | 32.8 | 32.9 | 34.9 | 21.3 |
| Probably not worth it | 8.4 | 7.1 | 8.7 | 13.3 |
| Definitely not worth it | 9.9 | 8.8 | 9.3 | 18.2 |
*
The percentages for each categorical variable may not add up to 100% due to rounding.
(++) or (+) indicates significant level between column 2 and column 3 /column 4 at .01 and .05, respectively.
(**)indicates significant level between column 3 and column 4 at .01 and .05, respectively.
These data are weighted to reflect the national sample of patients under care for HIV and physician nonresponse.
ID, infectious diseases; IVDA, intravenous drug abuse.